Plunkett Research Online: Zogenix Inc

ZOGENIX INC (ZGNX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Zogenix, Inc. is a pharmaceutical company that commercializes and develops products for the treatment of central nervous system disorders. Its current primary areas of therapeutic focus is on rare (orphan) childhood-onset epilepsy disorders. Zogenix owns and controls worldwide development and comm.....



Zogenix Inc
Ticker: ZGNX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 510-550-8300
Fax:
Address: 5858 Horton Street
Suite 455
Emeryville, CA 94608 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development & Manufacturing
ContactsDescription
Michael SmithCFO/Chief Accounting Officer/Executive VP/Secretary/Treasurer
Cam GarnerChairman of the Board/Director/Co-Founder
See More
Zogenix, Inc. is a pharmaceutical company that commercializes and develops products for the treatment of central nervous system disorders. Its current primary areas of therapeutic focus is on rare (orphan) childhood-onset epilepsy disorders. Zogenix owns and controls worldwide development and comm.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor: Latham & Watkins LLP
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
ZX008
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: